NEWCELX LTD

Historical 13F Holders

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

Each filer's latest filing for H5835A109 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
League Jinn Sarl 13D	25.3%	1,316,267	13D	5/4/2026 Event 4/27/2026
League Jinn Sarl	25.3%	1,316,267
Julien Ruggieri	25.3%	1,316,267
Michel Revel 13D	20.2%	940,787	13D	11/14/2025 Event 10/30/2025
Clover Wolf Capital - Limited Partnership 13G	7.5%	343,120	13G	11/7/2025 Event 10/30/2025
Clover Wolf Capital - Limited Partnership	7.5%	343,120
Adi Wolf	7.5%	343,120
Ronen Twito 13D	6.0%	272,399	13D	11/13/2025 Event 10/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Biotechnology Value Fund L P 13G/A	0.6%	28,732	13G/A	11/4/2025 Event 10/31/2025
Biotechnology Value Fund L P	0.3%	15,196
BVF I GP LLC	0.3%	15,196
Biotechnology Value Fund II LP	0.3%	11,746
BVF II GP LLC	0.3%	11,746
Biotechnology Value Trading Fund OS LP	<0.1%	1,334
BVF Partners OS Ltd.	<0.1%	1,334
BVF GP Holdings LLC	0.6%	26,942
BVF Partners L P/IL	0.6%	28,732
BVF Inc/IL	0.6%	28,732
Lampert Mark N	0.6%	28,732

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	2	13.0	$40	$0
2026 Q2	4	11.9 k	$42.6k	$0
2026 Q1	4	835	$1.77k	$0
2025 Q4	1	3.00	$6	$0